ONCS BRAS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.24 BRL | -6.79% |
|
-10.43% | -36.62% |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 5,254 | 2,889 | 6,603 | 4,188 | - | - |
| Enterprise Value (EV) 1 | 5,364 | 6,100 | 10,607 | 8,121 | 7,929 | 7,884 |
| P/E ratio | -98.7 x | 69.3 x | - | 16.7 x | 9.62 x | 9.15 x |
| Yield | - | - | - | 1.09% | 1.98% | - |
| Capitalization / Revenue | 1.94 x | 0.71 x | 1.2 x | 0.64 x | 0.55 x | 0.5 x |
| EV / Revenue | 1.99 x | 1.49 x | 1.93 x | 1.25 x | 1.04 x | 0.93 x |
| EV / EBITDA | 11.1 x | 7.96 x | 9.35 x | 6.68 x | 5.11 x | 4.54 x |
| EV / FCF | -25.4 x | -10.6 x | - | 109 x | 11.9 x | 9.26 x |
| FCF Yield | -3.94% | -9.44% | - | 0.92% | 8.42% | 10.8% |
| Price to Book | 2.88 x | 1.36 x | - | 1.45 x | 1.31 x | - |
| Nbr of stocks (in thousands) | 466,986 | 479,114 | 507,910 | 508,294 | - | - |
| Reference price 2 | 11.25 | 6.030 | 13.00 | 8.240 | 8.240 | 8.240 |
| Announcement Date | 3/29/22 | 3/28/23 | 3/27/24 | - | - | - |
1BRL in Million2BRL
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 2,035 | 2,702 | 4,088 | 5,489 | 6,504 | 7,607 | 8,433 |
| EBITDA 1 | - | 481.1 | 766.2 | 1,134 | 1,215 | 1,552 | 1,736 |
| EBIT 1 | - | 177.2 | 470.6 | 758 | 894 | 1,234 | 1,477 |
| Operating Margin | - | 6.56% | 11.51% | 13.81% | 13.75% | 16.22% | 17.52% |
| Earnings before Tax (EBT) 1 | - | 62.3 | 121.5 | 302.5 | 336.5 | 840.4 | 851 |
| Net income 1 | -38.54 | -22.4 | 46.26 | 312.6 | 247 | 510.7 | 561.6 |
| Net margin | -1.89% | -0.83% | 1.13% | 5.7% | 3.8% | 6.71% | 6.66% |
| EPS 2 | - | -0.1140 | 0.0870 | - | 0.4929 | 0.8561 | 0.9005 |
| Free Cash Flow 1 | - | -211.2 | -575.8 | - | 74.5 | 668 | 851.7 |
| FCF margin | - | -7.82% | -14.08% | - | 1.15% | 8.78% | 10.1% |
| FCF Conversion (EBITDA) | - | - | - | - | 6.13% | 43.03% | 49.07% |
| FCF Conversion (Net income) | - | - | - | - | 30.16% | 130.81% | 151.65% |
| Dividend per Share 2 | - | - | - | - | 0.0900 | 0.1633 | - |
| Announcement Date | 3/26/21 | 3/29/22 | 3/28/23 | 3/27/24 | - | - | - |
1BRL in Million2BRL
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 767.9 | 808 | 899.9 | 1,164 | 1,216 | 1,294 | 1,360 | 1,402 | 1,434 | 1,459 | 1,613 | 1,682 | 1,720 |
| EBITDA 1 | 140 | 141.3 | 158.9 | 213 | 253.1 | 291.7 | 285.4 | 285.4 | 271.7 | 254.4 | 337.1 | 329.3 | 330.5 |
| EBIT 1 | 73.1 | - | 76 | 131.1 | 190.9 | - | 187.6 | 184 | 177.7 | 166.8 | 258.8 | 250.7 | 245.6 |
| Operating Margin | 9.52% | - | 8.45% | 11.26% | 15.69% | - | 13.8% | 13.13% | 12.39% | 11.43% | 16.04% | 14.9% | 14.27% |
| Earnings before Tax (EBT) | - | - | - | 34.9 | 65.1 | - | 70.49 | - | 119.1 | - | - | - | - |
| Net income | - | - | - | 30.8 | 71.11 | - | 21.01 | 105 | 87 | 19.6 | - | - | - |
| Net margin | - | - | - | 2.65% | 5.85% | - | 1.55% | 7.49% | 6.07% | 1.34% | - | - | - |
| EPS 2 | 0.0374 | -0.0484 | -0.0700 | 0.0649 | 0.1389 | 0.0400 | 0.0398 | - | - | 0.0349 | 0.0690 | 0.1484 | 0.1648 |
| Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 3/29/22 | 5/16/22 | 8/15/22 | 11/10/22 | 3/28/23 | 5/15/23 | 8/14/23 | 11/13/23 | 3/27/24 | 5/13/24 | - | - | - |
1BRL in Million2BRL
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | 110 | 3,211 | 4,004 | 3,933 | 3,741 | 3,696 |
| Net Cash position 1 | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | 0.2289 x | 4.191 x | 3.531 x | 3.237 x | 2.41 x | 2.13 x |
| Free Cash Flow 1 | - | -211 | -576 | - | 74.5 | 668 | 852 |
| ROE (net income / shareholders' equity) | - | -0.99% | 2.33% | 14.1% | 9.15% | 15.5% | 18.8% |
| ROA (Net income/ Total Assets) | - | -0.48% | 0.65% | 3.59% | 1.92% | 3.51% | 4.27% |
| Assets 1 | - | 4,713 | 7,126 | 8,700 | 12,885 | 14,553 | 13,165 |
| Book Value Per Share 2 | - | 3.900 | 4.430 | - | 5.700 | 6.310 | - |
| Cash Flow per Share | - | - | - | - | - | - | - |
| Capex 1 | - | 202 | 304 | - | 483 | 335 | 396 |
| Capex / Sales | - | 7.47% | 7.44% | - | 7.43% | 4.4% | 4.7% |
| Announcement Date | 3/26/21 | 3/29/22 | 3/28/23 | 3/27/24 | - | - | - |
1BRL in Million2BRL
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
8.24
BRL
Average target price
13.69
BRL
Spread / Average Target
+66.11%
EPS Revisions
- Stock Market
- Equities
- ONCO3 Stock
- Financials ONCS BRAS
